La efectividad del Albendazol en el tratamiento de la estrongiloidiasis en niños
Abstract
The efficacy and tolerance of a new anthelmintic drug, Albendazole, was determined in the tratment of 13 children infected with S. stercoralis, in Córdoba, municipality of Buenaventura, Colombia. The study comprising children aged 2-6 years, of both sees, includet administration of 400 mg daily as a single oral dose, for three consecutive days. From a initial prevalence of 16% (n=124), the cure rates were assessed following Baermann's techinique, with samples obtained 7 and 21 days; after the final dose of the drug. A mean cure rate of 76.9% was achieved, with an excellent tolerance to the drug. From this results, it may be suggested that Albendazole should be considered the drug of choice for this of parasite.Downloads
Download data is not yet available.
How to Cite
1.
Domínguez A, Alzate A. La efectividad del Albendazol en el tratamiento de la estrongiloidiasis en niños. biomedica [Internet]. 1988 Jun. 1 [cited 2024 May 17];8(1-2):43-5. Available from: https://revistabiomedica.org/index.php/biomedica/article/view/1951
Issue
Section
Short communication
Article metrics | |
---|---|
Abstract views | |
Galley vies | |
PDF Views | |
HTML views | |
Other views |